Filing Details

Accession Number:
0000882104-15-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-17 06:02:23
Reporting Period:
2015-08-13
Filing Date:
2015-08-17
Accepted Time:
2015-08-17 06:02:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882104 Pdl Biopharma Inc. PDLI Biological Products, (No Disgnostic Substances) (2836) 943023969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188956 S Peter Garcia C/O Pdl Biopharma, Inc.
932 Southwood Blvd.
Incline Village NV 89451
Vice President, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-13 7,800 $5.86 83,672 No 4 P Direct
Common Stock Acquisiton 2015-08-13 2,200 $5.86 85,872 No 4 P Direct
Common Stock Acquisiton 2015-08-14 2,400 $5.79 88,272 No 4 P Direct
Common Stock Acquisiton 2015-08-14 7,300 $5.79 95,572 No 4 P Direct
Common Stock Acquisiton 2015-08-14 300 $5.80 95,872 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct